SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-015366
Filing Date
2019-05-02
Accepted
2019-05-02 16:31:34
Documents
73
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 MARCH 31, 2019 FORM 10-Q alny-10q_20190331.htm 10-Q 2044096
2 EX-10.1 alny-ex101_348.htm EX-10.1 39211
3 EX-31.1 alny-ex311_6.htm EX-31.1 18232
4 EX-31.2 alny-ex312_11.htm EX-31.2 18330
5 EX-32.1 alny-ex321_8.htm EX-32.1 7084
6 EX-32.2 alny-ex322_9.htm EX-32.2 7061
7 GRAPHIC g40cuqezchcs000001.jpg GRAPHIC 35071
  Complete submission text file 0001564590-19-015366.txt   6702654

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT alny-20190331.xml EX-101.INS 1429381
9 XBRL TAXONOMY EXTENSION SCHEMA alny-20190331.xsd EX-101.SCH 46317
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alny-20190331_cal.xml EX-101.CAL 61821
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alny-20190331_def.xml EX-101.DEF 128444
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE alny-20190331_lab.xml EX-101.LAB 335155
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alny-20190331_pre.xml EX-101.PRE 261564
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36407 | Film No.: 19792394
SIC: 2834 Pharmaceutical Preparations